INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/02/2026
Back to search
Official data from USPTO
EXIQON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXIQON
ST13
US500000079204234Class
1, 5, 9, 42
Filing
79204234
Registration
5547745
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
07/02/2026
Trademark type
Word
Nice classes
1, 5, 9, 42
Filing date
10/04/2016
Registration date
08/28/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2025
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
DE
Examiner
MCCARTHY, BRIDGET ANN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
QIAGEN GmbH
Exiqon A/S
Representatives
LETT LAW FIRM
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological productsreagents and tissues and reagents for industrial and scientific purposes; diagnostic reagentsexcept for medical or veterinary use; biochemical reagents and productscomprising industrial chemicalscatalysts for chemical and biochemical processes and chemical assays for analysis of nucleic acidnucleotide basesoligo nucleotide basesDNA and RNAused for non-medical purposes; chemical reagents except for medical or veterinary purposes; biochemical kits comprising chemicalscatalysts for chemical and biochemical processeschemical and biochemical assaysbiochemical probesbiochemical reagents and enzymesnot for medical or veterinary purposesfor analysis of genesnucleic acidnucleotide basesoligo nucleotide basesDNARNA and microRNA and for detecting RNA and microRNA; biochemical probes and microarray probes for analysis of DNARNAnucleotide basesoligo nucleotide basesnucleic acid and for detecting RNA and microRNA - not for medical and veterinary purposes
Class 5
Chemicalbiochemical and biological preparationsproductsreagents and tissuesreagents for pharmaceuticalmedical and veterinary purposesclinical medical reagentsdiagnostic reagentsassays for medical use; chemical pharmaceutical preparationsfor use in the detection of cancer in humans and animals and for use in oncology and for use in the preventiontreatment and cure of cancer; chemical reagents for medical and veterinary purposes; chemical preparations for therapeutic purposes for the detection of cancer in humans and animals and for the treatmentprevention and cure of cancer and for use in oncology; diagnostic preparations for medical and veterinary purposes
Class 9
Apparatus for recordingtransmission and reproduction of sound or images; prerecorded magnetic data carriers featuring information about biochemical research results and biochemical products and solutions for use in database managementprerecorded recording discs featuring information about biochemical research results and biochemical products and solutions for use in database management; compact discsfeaturing data for use in connection with chemical and biochemical analyses of genesDNARNAnucleic acidnucleotide basesoligo nucleotide bases; DVDsfeaturing data for use in connection with chemical and biochemical analyses of genesDNARNAnucleic acidnucleotide basesoligo nucleotide bases and other digital recording mediaprerecorded digital video discs and prerecorded digital versatile discs featuring information about biochemical research results and biochemical products and solutions; downloadable computer software for use in database management; downloadable cloud computing software for managing virtual machines on a cloud computing platformapplication software for computers for use in database management
Class 42
Researchdevelopment of chemicalbiochemical and biological productsindustrial analysisvalidation experiments and non-business consultancy relating to chemical analyses of genesnucleic acidnucleotide basesoligo nucleotide basesDNARNA and microRNA; biotechnical consultancy relating to genesnucleic acidnucleotide basesoligo nucleotide basesDNARNA and microRNApeptide syntheses and nucleotide syntheses; assay developmentscreening biomarker detection and development projects in the nature of biochemical and biological product developmentsampling of biochemical and biological productsmethod development of analysis of genesnucleic acidnucleotide basesoligo nucleotide basesDNARNA and microRNA and validation projects in the nature of analysis of genesnucleic acidnucleotide basesoligo nucleotide basesDNARNA and microRNAthe aforesaid services for use in relation to biotechnological industry and biotechnological and biological research and development; biochemical and biological sequencingthe aforesaid services for use in relation to biotechnological industry and biotechnological and biological research and development; design and development of computer softwareincluding cloud computing and application software for computers; scientific consultancy services relating to DNA peptide and nucleotide syntheses
Publications
History of USPTO decisions and trademark events.
40 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/11/2026
INPC
INVALIDATION PROCESSED
06/11/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/14/2025
C71T
CANCELLED SECTION 71
03/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/03/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/19/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/15/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/05/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/13/2018
FIMP
FINAL DISPOSITION PROCESSED
12/12/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/28/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/28/2018
PUBO
PUBLISHED FOR OPPOSITION
06/12/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/23/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/23/2018
NPUB
NOTICE OF PUBLICATION
05/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2018
CNRT
NON-FINAL ACTION MAILED
11/16/2017
CNRT
NON-FINAL ACTION WRITTEN
11/15/2017
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
11/08/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2017
ALIE
ASSIGNED TO LIE
10/23/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/30/2017
RFNT
REFUSAL PROCESSED BY IB
05/13/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/21/2017
RFRR
REFUSAL PROCESSED BY MPU
04/21/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/19/2017
CNRT
NON-FINAL ACTION WRITTEN
04/18/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/07/2017
DOCK
ASSIGNED TO EXAMINER
04/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/30/2017
Continuous trademark protection
Get notified about every new filing that threatens EXIQON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.